4893 items matching your search terms.

Can time to progression on last line treatment inform us about post-progression survival time in advanced gastric cancer?

Vasista, A. Martin, A. Pavlakis, N. Sjoquist, K.M. Goldstein, D. Shapiro, J. Karapetis, C. Gill, S. Jain, V. Kannourakis, G Kim, Y.H. Wigston (Nott), L. Snow, S. Harris, D. Jonker, D. Chua, Y.J. Stockler, M. Keily, B.

Accuracy and prognostic significance of oncologists’ estimates and scenarios for survival time in a randomised phase II trial of regorafenib in advanced gastric cance

Vasista, A. Martin, A. Pavlakis, N. Sjoquist, K.M. Snow, S. Jonker, D. Chua, Y.J. Epstein, R. Bonaventura, A. Khasraw, M. Varma, S. Singhal, N. Ransom, D. Aubin, F. Burkes, R. Lim, H. Lemay, F. Begbie, S. Stockler, M. Keily, B.

More than just the median: calculating survival times for patients with HER2 positive, metastatic breast cancer using data from recent randomised trials

Vasista, A. Stockler, M. R. West, T. Wilcken, N. Kiely, B. E.
BREAST, 2017     DOI:10.1016/j.breast.2016.10.007

High-dose intravenous methotrexate with high-flux haemodialysis in treatment of post-transplant, central nervous system lymphoma with end-stage kidney disease

Vaughan, E. Yeung, J. Brown, C. Chadban, S. Thiagarajah, N. Saunders, J.

Erratum to: Innovative technology shows impact of glycaemic control on peripheral retinal vessels in adolescents with type 1 diabetes

Velayutham, V. Benitez-Aguirre, P. Z. Craig, M. E. Liew, G. Wong, T. Y. Jenkins, A. J. Donaghue, K. C.
DIABETOLOGIA, 2017     DOI:10.1007/s00125-017-4454-5

Innovative technology shows impact of glycaemic control on peripheral retinal vessels in adolescents with type 1 diabetes

Velayutham, V. Benitez-Aguirre, P. Z. Craig, M. E. Liew, G. Wong, T. Y. Jenkins, A. J. Donaghue, K. C.
DIABETOLOGIA, 2017     DOI:10.1007/s00125-017-4375-3

How will transitioning from cytology to HPV testing change the balance between the benefits and harms of cervical cancer screening? Estimates of the impact on cervical cancer, treatment rates and adverse obstetric outcomes in Australia, a high vaccination coverage country

Velentzis, L. S. Caruana, M. Simms, K. T. Lew, J. B. Shi, J. F. Saville, M. Smith, M. A. Lord, S. J. Tan, J. Bateson, D. Quinn, M. Canfell, K.
INTERNATIONAL JOURNAL OF CANCER, 2017     DOI:10.1002/ijc.30926

Protocol for combined analysis of FOXFIRE, SIRFLOX, and FOXFIRE-Global randomized phase iii trials of chemotherapy +/- selective internal radiation therapy as first-line treatment for patients with metastatic colorectal cancer

Virdee, P. S. Moschandreas, J. Gebski, V. Love, S. B. Francis, E. A. Wasan, H. S. van Hazel, G. Gibbs, P. Sharma, R. A.
JMIR RES PROTOC, 2017     DOI:10.2196/resprot.7201

HDL as a target for glycemic control

Waldman, B. Jenkins, A. J. Sullivan, D. Ng, M. K. C. Keech, A. C.
CURRENT DRUG TARGETS, 2017     DOI:10.2174/1389450116666150727115544

Improving the development, monitoring and reporting of stroke rehabilitation research: consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable

Walker, M. F. Hoffmann, T. C. Brady, M. C. Dean, C. M. Eng, J. J. Farrin, A. J. Felix, C. Forster, A. Langhorne, P. Lynch, E. A. Radford, K. A. Sunnerhagen, K. S. Watkins, C. L.
INTERNATIONAL JOURNAL OF STROKE, 2017     DOI:10.1177/1747493017711815

Home hemodialysis: a comprehensive review of patient-centered and economic considerations

Walker, R. C. Howard, K. Morton, R. L.
CLINICOECON OUTCOMES RES, 2017     DOI:10.2147/CEOR.S69340

"Who matters most?": clinician perspectives of influence and recommendation on home dialysis uptake

Walker, R. C. Marshall, R. Howard, K. Morton, R. L. Marshall, M. R.
NEPHROLOGY (CARLTON), 2017     DOI:10.1111/nep.12920

Maori patients' experiences and perspectives of chronic kidney disease: a New Zealand qualitative interview study

Walker, R. C. Walker, S. Morton, R. L. Tong, A. Howard, K. Palmer, S. C.
BMJ OPEN, 2017     DOI:10.1136/bmjopen-2016-013829

Muscle strength, mobility, quality of life and falls in patients on maintenance haemodialysis: A prospective study

Wang, A. Y. Sherrington, C. Toyama, T. Gallagher, M. P. Cass, A. Hirakawa, Y. Li, Q. Sukkar, L. Snelling, P. Jardine, M. J.
NEPHROLOGY (CARLTON), 2017     DOI:10.1111/nep.12749

Poor prognosis after second locoregional recurrences in the CALOR trial

Wapnir, I. L. Gelber, S. Anderson, S. J. Mamounas, E. P. Robidoux, A. Martin, M. Nortier, J. W. Geyer, C. E., Jr. Paterson, A. H. Lang, I. Price, K. N. Coates, A. S. Gelber, R. D. Rastogi, P. Regan, M. M. Wolmark, N. Aebi, S. Calor trial investigators
ANNALS OF SURGICAL ONCOLOGY, 2017     DOI:10.1245/s10434-016-5571-y